These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26742264)

  • 1. The push to reconcile the gap in LDT regulations.
    Farmer T
    MLO Med Lab Obs; 2015 Dec; 47(12):14-6. PubMed ID: 26742264
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory-developed tests are not the practice of medicine.
    Allen JS
    MLO Med Lab Obs; 2015 Sep; 47(9):46. PubMed ID: 26495599
    [No Abstract]   [Full Text] [Related]  

  • 3. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance.
    Sidawy MK
    Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.
    Hillebrenner E; Litwack E; Bradley P; Donigan K; Lowe T; Serrano K; Kelm K; Mansfield E; Gutierrez A
    J Clin Pharmacol; 2015 Jul; 55(7):728-30. PubMed ID: 26053648
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients' access to test reports: changes to CLIA regulations and HIPAA Privacy Rule.
    Joint Commision on Accreditation of Healthcare Organizations
    Jt Comm Perspect; 2014 Jun; 34(6):7, 9. PubMed ID: 25244901
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory-Developed Tests: A Legislative and Regulatory Review.
    Genzen JR; Mohlman JS; Lynch JL; Squires MW; Weiss RL
    Clin Chem; 2017 Oct; 63(10):1575-1584. PubMed ID: 28687634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Laboratory Improvement Amendments of 1988 (CLIA); Fecal Occult Blood (FOB) Testing. Final rule.
    ;
    Fed Regist; 2017 Oct; 82(202):48770-3. PubMed ID: 29090890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing.
    Levy KD; Pratt VM; Skaar TC; Vance GH; Flockhart DA
    J Clin Pharmacol; 2015 Jul; 55(7):725-7. PubMed ID: 26053647
    [No Abstract]   [Full Text] [Related]  

  • 9. US officials ban Theranos CEO from running laboratories for two years.
    McCarthy M
    BMJ; 2016 Jul; 354():i3824. PubMed ID: 27401465
    [No Abstract]   [Full Text] [Related]  

  • 10. ACLA represents the interests of the clinical lab in an uncertain regulatory climate.
    Lenhoff A
    MLO Med Lab Obs; 2016 Jun; 48(6):44. PubMed ID: 27451531
    [No Abstract]   [Full Text] [Related]  

  • 11. Notification of highly abnormal laboratory results to doctors outside hospitals.
    Aakre KM; Hov GG; Skadberg O; Piehler A; Distante S; Hager HB
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):E1-6. PubMed ID: 24226343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Notification of highly deviant biochemical analysis results].
    Aakre KM; Hov GG; Skadberg Ø; Piehler A; Distante S; Hager HB
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2240-1. PubMed ID: 24226328
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical laboratory improvement amendments waivers.
    Clark JR
    Air Med J; 2013; 32(5):234-5. PubMed ID: 24001908
    [No Abstract]   [Full Text] [Related]  

  • 14. Proposed, enacted, and future laboratory legislation.
    Kasoff J; Buescher T
    MLO Med Lab Obs; 2013 Jul; 45(7):44, 46-8. PubMed ID: 24180075
    [No Abstract]   [Full Text] [Related]  

  • 15. Co-creating critical limits for enhanced acute care: proven need and web knowledge base. Part 2: Standard of care, what it means and how it is applied.
    Kost GJ
    MLO Med Lab Obs; 2016 Jan; 48(1):28-9. PubMed ID: 26887097
    [No Abstract]   [Full Text] [Related]  

  • 16. Tighter gene tests.
    Fox J
    Nat Biotechnol; 2008 Jul; 26(7):721. PubMed ID: 18612277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines for the pre-examination processing and transport of medical laboratory samples].
    Annette-Reisch M; Soubiran P; Szymanowicz A;
    Ann Biol Clin (Paris); 2010 Dec; 68 Spec No 1():111-29. PubMed ID: 21613010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory developed tests: what may be coming.
    Jones PM
    MLO Med Lab Obs; 2012 Oct; 44(10):24, 26. PubMed ID: 23091959
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA regulation of LDTs--an update.
    Jones PM
    MLO Med Lab Obs; 2015 Sep; 47(9):18-9. PubMed ID: 26495591
    [No Abstract]   [Full Text] [Related]  

  • 20. CLINICAL LABORATORY SERVICE FOR GEOGRAPHIC REGIONS.
    THOMAS RG
    Hosp Prog; 1965 Jun; 46():88-92. PubMed ID: 14297624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.